RAC 1.74% $1.47 race oncology ltd

Ann: Race Initiates FTO Directed Kidney Cancer Preclinical Study, page-90

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 965 Posts.
    lightbulb Created with Sketch. 555
    you're right.
    No bad news, yet we've gone backwards.
    People chasing the next Hot thing, or losing patience or they simply don't get FTO. Perhaps, market Still think boring old chemo drug with heaps of side effects..
    All that doesn't change the fact we are at least 8 times undervalued compared to US Biotechs( just on preclinical data)...
    I believe, us LTH will be rewarded handsomely some day when the overall market wakes up to the FTO blockbuster.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.47
Change
0.025(1.74%)
Mkt cap ! $249.7M
Open High Low Value Volume
$1.44 $1.48 $1.44 $25.63K 17.46K

Buyers (Bids)

No. Vol. Price($)
1 312 $1.47
 

Sellers (Offers)

Price($) Vol. No.
$1.48 354 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.